Observational Study
Copyright ©The Author(s) 2024.
World J Hepatol. Jun 27, 2024; 16(6): 920-931
Published online Jun 27, 2024. doi: 10.4254/wjh.v16.i6.920
Figure 2
Figure 2 Liver histological changes in different clinical phases. A: Proportions of chronic hepatitis B patients in different clinical phases; B: The liver histological changes in different clinical phases using liver biopsy. Four phase including including immune tolerant phase, HBeAg-positive immune active phase, inactive phase, and HBeAg-negative immune active phase. ≥ G2 was defined by significant necroinflammation, ≥ S2 defined by significant fibrosis, and ≥ G2/S2 defined by significant histopathological changes.